Neupro patch 6

The most common side effects in people taking NEUPRO for Parkinson's disease are nausea, vomiting, sleepiness, application site reactions, dizziness, loss of appetite, difficulty falling asleep and staying asleep, increased sweating, vision problems, leg swelling, and uncontrolled, sudden movements of the arms or legs.

For more information, ask your doctor or pharmacist. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www. You may also report side effects to UCB, Inc. This information does not take the place of talking with your healthcare provider about your condition or treatment. All rights reserved. If you arrive at a site that is not sponsored by UCB, please note that UCB is not responsible for the content or services of that site or any further links from that site.

UCB is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site or its content by UCB. Please be aware that the linked site may be governed by its own set of terms and conditions and privacy policy, for which UCB has no responsibility.

Toggle navigation. Main navigation Why Neupro? Start saving today. Which of the following best describes you? Year Year Does the patient currently have commercial also known as private insurance? Sorry, you are not eligible at this time. Offer good only in the U. This card is good for use only with a valid NEUPRO prescription consistent with the approved FDA labeling at the time the prescription is filled by the pharmacist and dispensed to the patient.

Void where prohibited by law, taxed, or restricted. This offer cannot be combined with any other promotional offer. UCB, Inc. No cash value. Not eligible for sale, purchase, trade, or counterfeit. Patients who have been prescribed a lower dose or who have been withdrawn from the drug should be informed about potential withdrawal symptoms and monitored during and after discontinuation.

Please see full Prescribing Information. All rights reserved. UCB Inc. If you arrive at a site that is not sponsored by UCB, please note that UCB is not responsible for the content or services of that site or any further links from that site. UCB is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site or its content by UCB. Please be aware that the linked site may be governed by its own set of terms and conditions and privacy policy, for which UCB has no responsibility.

Toggle navigation. Onset of treatment benefit started as early as the first week of treatment. NEUPRO is a transdermal system that provides continuous delivery of rotigotine for 24 hours following application to intact skin.

The safety of NEUPRO was evaluated in a total of early-stage PD patients who participated in three double-blind, placebo-controlled studies with durations of 3 to 9 months. Additional safety information was collected in short-term studies and two open-label extension studies in patients with early-stage PD. The safety evaluation of NEUPRO was based on a total of NEUPRO-treated patients with advanced-stage PD who participated in three double-blind, placebo-controlled studies two fixed-dose trials and one flexible-dose trial with durations of 3 to 7 months.

Patients received concomitant levodopa in these studies. Additional safety information was collected in earlier short-term studies and two open-label extension studies in patients with advanced-stage PD. Other patient resources. Product Use Brochure Illustrated, step-by-step use instructions.

Patch Placement Tracker A tool to help patients rotate their patch daily. Important Safety Information NEUPRO contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people and is seen more frequently in people with asthma.

Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease.

If you stop using NEUPRO, you may have withdrawal symptoms such as fever, confusion, severe muscle stiffness, feeling like you do not care about the things you usually care about apathy , anxiety, depression, fatigue, insomnia, sweating and pain.

Tell your doctor if you have breathing problems, a sleep disorder, mental problems, high or low blood pressure, or heart problems; are pregnant or plan to become pregnant; or are breastfeeding or plan to breastfeed. The most common side effects in people taking NEUPRO for Restless Legs Syndrome are application site reactions, nausea, difficulty falling asleep and staying asleep, sleepiness, and headache. For more information, ask your doctor or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www. You may also report side effects to UCB, Inc. This information does not take the place of talking with your healthcare provider about your condition or treatment. All rights reserved. If you arrive at a site that is not sponsored by UCB, please note that UCB is not responsible for the content or services of that site or any further links from that site.

UCB is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site or its content by UCB. Please be aware that the linked site may be governed by its own set of terms and conditions and privacy policy, for which UCB has no responsibility.